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Abstract: 
Learning about possible factors influencing, positively or negatively, the Quality of Life (QoL) 
of patients with psychosis is an important task for both, research and treatment. The study 
examined the association of illness course with QoL in a sample of Mexican patients with 
psychosis. It was hypothesized that illness perception would mediate the relation of illness 
course to QoL. Sixty-one (56 % female) patients were interviewed and assessed for illness 
course (relapses, residual symptoms, and diagnosis), QoL, and illness perception. Mediation 
analyses (simple and multiple) with bootstrapping procedures were applied, including residual 
symptoms as the predictor of QoL, and illness perception dimensions as candidate mediators. 
Residual symptoms, rather than a relapsing course or a diagnosis of schizophrenia, have a 
diminishing effect in the subjective QoL. This effect is fully mediated by illness perception, 
particularly by the cognitive and the emotional representations. Results underscore the 
importance that patients’ beliefs have on their perceived QoL, encouraging further research and 
development of interventions targeting illness perceptions. 
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Introduction 
Patients’ quality of life (QoL) has become an important issue in patient care and, in consequence, 
in research, reflecting a re-emerging biopsychosocial perspective of health. The concept of QoL 
has long been applied in medical conditions, and more recently expanded to psychiatric disorders 
(Awad and Voruganti 2000). 
Even though schizophrenia spectrum psychoses can be considered as the most disabling of all 
mental disturbances, advances in treatment approaches, including antipsychotic medication, have 
made clinical stability achievable for patients and meant that QoL is a feasible aim in the 
patient’s process of reintegration to family and community life. Despite some methodological 
limitations (Browne et al. 2000; Gladis et al.1999), research indicates that people with 
schizophrenia suffer significantly poorer QoL (Pinikahana et al. 2002). Moreover, impaired QoL 
has been observed in patients with a first-episode of psychosis (Bechdolf et al. 2005; Browne et 
al. 2000; Theodore et al. 2011), prodromal (Bechdolf et al. 2005; Ruhrmann et al. 2008) and 
even psychosis-vulnerable subjects (Svirskis et al. 2007). Nevertheless, follow-up studies have 
shown that after a first psychotic episode is treated, QoL might plateau (Górna et al. 2008) and 
even improve (Foldemo and Bogren 2002; Malla et al. 2001; Ritsner et al. 2003). 
Various sociodemographic (Pinikahana et al. 2002), clinical (Gaite et al. 2002; Malla and 
Payne 2005; Ritsner et al. 2003), social (Caron et al. 2005; Gaite et al. 2002; Ritsner et al. 2003) 
and treatment factors (Pinikahana et al. 2002) have been identified as reliable predictors of QoL, 
although their effect might be influenced by cultural issues (Gaite et al. 2002; Pinikahana et 
al. 2002). The course of psychotic illness might be an important factor related to QoL. Although 
not all evidence concurs (Almond et al. 2004), a relapsing course might lead to functional 
deterioration and diminished stability in employment and relationships (Nasrallah and 
Lasser 2006), in turn affecting QoL. Also, residual psychopathology might diminish QoL (Malla 
and Payne 2005; Savilla et al. 2008; Thorup et al. 2010), disrupting functioning and causing 
distress (Rudnick 2001); particularly negative symptoms (Hirschberg 2006; Narvaez et al. 2008; 
Pinikahana et al. 2002). In regard to diagnostic course, although schizophrenic psychoses show a 
poorer global outcome (Möller et al. 2000; Ritsner et al. 2000), they do not seem to differ from 
other psychoses in regard to QoL (Ritsner et al. 2003). Improving our understanding of factors 
mediating the effect of illness course on the QoL of patients with psychosis should improve 
patient care and increase the likelihood of satisfactory recovery beyond symptom remission. 
The concept of “illness perception” or “illness appraisal” (Leventhal et al. 1984) has attempted to 
explain how people create a private representation of their illness in order to make sense of and 
respond adequately to the situation. Attribution and perception of mental illness might prompt or 
delay help-seeking, determine pathways to mental health care and affect prognosis (Burns et 
al. 2011). Whether seen as an illness or otherwise, the experience of psychosis raises individual’s 
beliefs involving not only the acknowledgement of health status, but also the appraisal of 
personal and social consequences (Watson et al. 2006). Among mental health patients, it is not 
unusual to find partial awareness of their illness that might be addressed as “personal 
difficulties,” “stress” or “nervousness.” This might be due to denial, a limited educational level, 
or even to mildness of symptoms. Illness perception does not require acknowledging the 
condition as a disorder; thus, patients can recognize being affected (or not) regardless of their 
comprehension of and insight into mental illness. Illness perceptions involve cognitive and 
emotional representations (Broadbent et al. 2006; Leventhal et al. 1984; Moss-Morris et al. 2002) 
that have been related to QoL in various medical conditions (Miglioretti et al. 2008; Scharloo et 
al. 2007) and in psychosis as well (Lobban et al. 2004; Stainsby et al.2010; Theodore et al. 2011; 
Watson et al. 2006). Patients with psychosis are undeniably in risk of temporary or chronic 
deterioration; however, focus must be placed not only on the mere amelioration of symptoms and 
prevention of relapses, but also on the achievement of satisfactory levels of QoL. Learning about 
possible factors influencing, positively or negatively, the QoL of patients with psychosis is an 
important task for both, research and treatment. Reports of patients with psychosis from Mexico 
are limited; data from this population might not only help to corroborate or refute the findings of 
previous research from other countries, but would also provide valuable clues in regard to 
predictive and mediating variables of QoL that might be proper to this culture. The present study 
examined the association of illness course with QoL in a sample of Mexican patients with 
psychosis. Although both illness course and illness perception have been reported to have a 
significant effect on the QoL of patients with psychosis, to the best of our knowledge these two 
variables have not been yet simultaneously studied. The present study undertakes this task and 
further proposes a model where illness perception might play a mediating role between illness 
course and its effect on QoL. 
Methods 
Sample 
Participants for this study were patients who have received mental health care in the adult service 
of the Hospital Psiquiatrico Yucatan in Mexico. This hospital does not have a delimited 
catchment area as it offers attention for mental health to all in need regardless of residence and 
availability of medical insurance. Sampling was restricted to the inhabitants of the city of 
Merida, where the hospital is located. After obtaining formal authorization and ethical approval 
from the Hospital Committee, clinical files were reviewed in search of patients who would meet 
the following criteria: i) occurrence of a first episode of psychosis between 1999 and 2005; ii) 
age at onset 16–45 years; and iii) a primary current DSM-IV-TR (American Psychiatric 
Association—APA 2000) diagnosis of schizophrenia or other schizophrenia-spectrum psychotic 
disorder. Exclusion criteria were: i) a DSM-IV-TR diagnosis of psychosis of affective, organic, 
or toxic type (APA 2000), ii) an evident intellectual disorder, and iii) inadequate contact 
information. 
From a total of 158 potential cases, 55 had moved away and could not be located. From the 
remaining 103, 66 (64 %) agreed to be interviewed (with no economic compensation involved) 
signing informed consent. Five participants were unable to provide reliable data due to high 
symptom severity; thus, the final sample included 61 patients (56 % female). Thirty-four (56 %) 
participants had secondary or lower education (up to 9th grade) and the remaining 27 (44 %) had 
partial/complete medium or higher education. At the time of the assessment, no participant was 
hospitalized. In terms of current DSM-IV-TR diagnoses, 41 patients had schizophrenia (14 
paranoid, 2 disorganized, and 25 residual) and 20 patients had other types of schizophrenia-
spectrum psychoses (8 schizoaffective, 7 delusional, 2 schizophreniform, 2 brief, and 1 not 
otherwise specified). Mean illness course was 6.7 years (SD = 1.9, range 3.8–11.2). Current 
mean age was 35.9 years (SD = 10.0). Mean age at onset was 29.1 years (SD = 9.8); although an 
atypical value it is consistent with previous studies in Mexican samples (Apiquián et al. 1997). 
There were no significant sex differences for either current (t(59) = −1.06, p = 0.29) or onset 
(t(59) = −1.01, p = 0.32) age. Gender, educational level, current and onset age were not 
significantly related to QoL. Of the total sample, 25 patients (41 %) were not currently receiving 
outpatient treatment. Four of them (2 with brief psychosis and 2 with schizophreniform 
disorder), had received medical discharge. The remaining 21 had dropped out from regular 
outpatient follow-up. However, these 21 patients did not show any difference in our outcome 
variable, QoL, compared to the 36 who followed out-patient treatment (CSCV-Favorable, 
t(55) = −1.37; CSCV-Disfavorable, t(55) = 1.21). Therefore, current treatment status was not 
considered for the analyses. 
Measures 
Based on both, information from clinical files and SCID-I (Structured Clinical Interview for 
DSM-IV-TR Axis I Disorders; (First et al. 1995) interviews with patients, the illness course of 
each patient at the time of assessment was established for three dichotomously scored criteria: i) 
any recorded relapse (i.e. exacerbation of psychotic symptoms requiring hospitalization and/or 
increase in medication (Rosen and Garety 2005) in the time period from the first episode to 
participation in the study), ii) the current presence of residual symptoms (only negative 
symptoms or two or more positive symptoms present in an attenuated form (APA 2000)) and, iii) 
the current primary psychotic diagnosis according to the DSM-IV-TR criteria (APA 2000; First 
et al. 1995). Even though the complexity of illness course is undeniable, simplifying it into two 
categories for research purposes has provided significant results (Altamura et al. 2001; Gómez-
de-Regil et al.2010; Rosen and Garety 2005; Vázquez-Barquero et al. 1999). 
QoL was assessed with the Sevilla Quality of Life Questionnaire (CSCV, Cuestionario Sevilla de 
Calidad de Vida), a 59-item self-rated questionnaire developed in Spanish for patients with 
schizophrenia (Giner et al.1997). This questionnaire has two subjective QoL scales: the 
Favorable-aspect scale (CSCV-Favorable) composed of vital satisfaction, self-esteem and 
harmony factors; and the Disfavorable-aspect scale (CSCV-Disfavorable) composed of lack of 
cognitive apprehension, loss of energy, lack of inner control, difficulty with emotional 
expression, difficulty with cognitive expression, oddness, fear of losing control, restrained 
hostility, and automatism factors. The instrument has satisfactory levels of reliability and validity 
(Ibañez et al. 1997) that have been replicated in samples from Latin America (Alvarado and 
Muñoz 2006). 
Illness perception was measured with the Brief Illness Perception Questionnaire (Brief-IPQ) 
(Broadbent et al.2006). This 8-item self-report scale assesses three dimensions of illness 
perception: cognitive representation (beliefs about illness’ severity, consequences, and duration, 
personal control over illness and usefulness of treatment), emotional representation (negative 
emotions about illness) and comprehensibility (understanding of the disorder). Higher scores of 
cognitive and emotional representations indicate a negative perception of illness, whereas higher 
scores on comprehensibility indicate a favorable perception. The instrument has shown good 
levels of validity and reliability (Broadbent et al. 2006) and although it is not exclusive for 
people with a mental illness, it has been satisfactorily applied to patients with psychosis 
(Broadbent et al. 2008). All scales were presented in a 4-point scale. 
Statistical Analysis 
First, the QoL of groups defined by the dichotomous illness course criteria (relapses, residual 
symptoms, and diagnosis) were compared with t-tests and the association of QoL with illness 
perception was estimated with Pearson correlations. Next, bivariate and partial correlations were 
applied to observe the direct and mediated effect (controlling for illness perception dimensions) 
of illness course on QoL. Following Preacher and Hayes (2004), simple mediation bootstrapping 
procedures were used to determine the significance of each mediator individually. Finally, 
following Preacher and Hayes (2008), the resulting significant mediators were entered 
simultaneously to confirm their effect. 
Results 
Regarding QoL levels, 82 % (n = 50) of participants scored in average above the 2.5 midpoint 
value (possible score range: 1 to 4) for CSCV-Favorable and up to 85 % (n = 52) below 2.5 for 
CSCV-Disfavorable. Descriptive data for illness perception and QoL measures are presented in 
Table 1. No significant differences by sex or educational level were found on any variable so the 
values are presented for the total sample. Onset and current age were not significantly correlated 
with any of the described variables. Cognitive representation was significantly correlated with 
the emotional representation (r = 0.50, p ≤ 0.001). 
Table 1 Mean and standard deviation of illness perception and quality of life scores (n = 61) 
Scales Mean (SD) Range 
Illness perception (Brief-IPQ) 
 Cognitive representation 10.7 (2.9) 5.0 – 17.0 
 Emotional representation 5.0 (2.1) 2.0 – 8.0 
 Comprehensibility 2.9 (1.1) 1.0 – 4.0 
Quality of life (CSCV) 
 Favorable 3.0 (0.7) 1.5 – 4.0 
 Disfavorable 1.7 (0.6) 1.0 – 3.4 
Possible score range for cognitive representation: 5.0 – 20.0; for emotional representation: 2.0 – 
8.0; for comprehensibility: 1.0 – 4.0 
Brief-IPQ Brief Illness Perception Questionnaire; CSCV Cuestionario Sevilla de Calidad de Vida 
(Sevilla Quality of Life Questionnaire) 
Data for illness course and its effect on QoL are presented in Table 2. Following Cohen (1992), a 
d-value of .2 indicates a small effect, .5 a medium effect, and .8 a large effect size. As it can be 
seen, the presence of residual symptoms was robustly associated with impaired QoL. 
Table 2 Differences in quality of life according to illness course (n = 61) 
Qualit
y of 
life 
subscal
es 
(CSCV
) mean 
(SD) 
Relapses Residual symptoms Diagnosis 
Any 
relapse
n = 37 
Single-
episode
n = 24 
t (5
9) 
Coh
en’s 
d 
Present
n = 30 
Absent
n = 31 
t (59
) 
Coh
en’s 
d 
Schizophre
nian = 41 
Other 
psychose
sn = 20 
t (5
9) 
Coh
en’s 
d 
Favora
ble 
2.9 
(0.7) 3.2 (0.6) 
−1.
33 0.46 2.8 (0.7) 
3.3 
(0.6) 
−2.9
9** 0.77 2.9 (0.7) 3.2 (0.5) 
−1.
59 0.49 
Disfav
orable 
1.8 
(0.6) 1.6 (0.5) 
1.2
9 0.36 1.9 (0.7) 
1.5 
(0.4) 
2.90
** 0.70 1.7 (0.6) 1.7 (0.7) 
−0.
19 0.00 
Medium effect sizes in bold 
CSCV Cuestionario Sevilla de Calidad de Vida (Sevilla Quality of Life Questionnaire) 
*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001 
Data for the association of QoL with illness perception are presented in Table 3. Overall, 
negative cognitive and emotional representations were significantly related to poorer QoL, 
whereas higher understanding of illness was related only to the favorable QoL score. Following 
Cohen (1992), a correlation of .10 represents a small effect, .3 a medium effect, and .5 a large 
effect. 
Table 3 Pearson correlations of quality of life with illness perception (n = 61) 
Quality of life subscales 
(CSCV) 
Illness perception (Brief-IPQ) 
Cognitive 
representation 
Emotional 
representation 
Comprehensibility 
Favorable −0.59*** −0.42*** 0.30* 
Disfavorable 0.62*** 0.45*** −0.18 
Significant results in bold 
Brief-IPQ Brief Illness Perception Questionnaire; GAF-F Global Assessment of Functioning 
Scale, Functioning Score; CSCV Cuestionario Sevilla de Calidad de Vida (Sevilla Quality of Life 
Questionnaire) 
p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001 
The residual symptom criterion was selected as the most reliable predictor of poor QoL, above 
diagnosis and relapses. Therefore, the final mediation analysis included residual symptoms as the 
predictor of QoL (CSCV-Favorable and CSCV-Disfavorable), and illness perception dimensions 
as candidate mediators. Results are shown in Table 4. A significant direct effect of residual 
symptoms on both QoL dimensions can be observed by bivariate correlations. However, the 
effect seemed fully mediated by the negative emotional representation of illness, as it was no 
longer significant when this mediator was entered in partial correlations. Negative cognitive 
representation and comprehension of illness failed to partially mediate the effect of residual 
symptoms on either QoL measure. Nevertheless, following Preacher and Hayes (2004), 
bootstrapping procedures revealed that both cognitive and emotional representation were 
individually significant mediators. Finally, by bootstrapping multiple mediation analysis 
(Preacher and Hayes 2008), only the statistically significant mediation effect of cognitive 
representation was corroborated. 
Table 4 Tests of mediation of the association of residual symptoms and quality of life by illness 
perception dimensions 
Predictor Outcome Direct 
effect 
Mediator Mediated 
effect 
Simple 
mediation 
Bootstrap 
95 % CI 
Multiple 
mediation 
Bootstrap 
95 % CI 
Residual 
symptoms 
CSCV-
Favorable 
−.36 ** Cognitive 
representation 
−.27* −.39 – −.00 −.38 – −.02 
Emotional 
representation 
−.25 −.32 – −.37 −.19 – .06 
Comprehensibility −.32* −.18 – .02 – 
CSCV-
Disfavorable 
.35 ** Cognitive 
representation 
.26* .00 – .34 .02–.35 
Emotional 
representation 
.23 .04 – .32 −.04 – .19 
Comprehensibility .33* −.05 – .14 – 
Direct effect is the bivariate correlation of Residual Symptom rating with the outcome measure; 
Mediated effect is the same correlation with the mediator partialed out. Simple mediation 
indicates the significance of mediation analyzed individually. Multiple mediation indicates the 
significance of mediation with the mediators entered simultaneously. Significant results in bold 
CSCV Cuestionario Sevilla de Calidad de Vida (Sevilla Quality of Life Questionnaire) 
*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001 
Discussion 
This is the first study not only reporting on the QoL of mental health patients from a particular 
Mexican population, but also analyzing the mediating role of illness perception between illness 
course and QoL. Our results not only corroborate the association between residual 
psychopathology and poor QoL (Jabs et al.2004; Malla and Payne 2005; Rudnick 2001; 
Theodore et al. 2011), but also provide a clear picture of the impact of residual symptoms above 
that of relapsing course and diagnosis. Additionally, the study also replicates the evidence in 
favor of an association between a diminished QoL and illness perception (Lobban et al. 2004; 
Stainsby et al. 2010; Theodore et al. 2011). 
The major finding of this study was that cognitive and emotional representations of illness, rather 
than comprehensibility, fully mediate the effect that residual symptoms have on the QoL of 
patients with psychosis. These results converge with Theodore et al. (2011) who found, in a 
sample of patients with early psychosis, that illness perception was significantly associated with 
QoL, particularly the cognitive (treatment control, negative consequences) and emotional 
dimensions; and that the former was the strongest predictor of QoL over and above 
symptomatolgy. Patients conceiving their illness as severe and long-lasting, unmanageable by 
treatment or personal control, and seriously affecting their lives, experience a diminished QoL. 
An illness perceived as uncontrollable and highly intrusive might compromise QoL by reducing 
gratification from psychologically valued activities and, by diminishing personal control as the 
ability to obtain positive outcomes and/or to avoid negative ones becomes limited (Devins 2010). 
The adversity of psychopathology comes not only from the psychological distress it causes, but 
also, and mainly, from how it affects the social dimension, by limiting the attainment of 
“personal projects” (Shahar and Davidson 2009). Evidence supports that family and social 
dimensions of life, which might provide attachment and reassurance of worth, are very important 
to patients’ QoL (Caqueo-Urízar and Lemos-Giráldez 2008; Caron et al. 2005; Lundberg et 
al. 2008; Pitkänen et al. 2009) and might even reduce the risk of suicide in patients with 
schizophrenia (Kao et al. 2011). Patients’ sense of recovery does not unfold in isolation, but 
within a social and interpersonal context (Harvey et al. 2007; Ng et al. 2008; Schön et al. 2009; 
Topor et al. 2011). The reintegration of patients’ to their daily family and community roles might 
can be hindered by persistent and intrusive residual symptoms and the resulting negative 
cognitive perception of illness, restringing their opportunities to obtain social reinforcement and 
improve QoL. Although this possibility cannot be directly drawn from our results, it is an idea 
worth of further study. 
The emotional representation (concerns and emotions) of illness is also an important mediator of 
the effect of residual symptoms on the QoL. Illness perception has been related to positive and 
negative symptoms (Lobban et al. 2005) as well as anxiety and depression (Huppert and 
Smith 2001; Priebe et al. 2000) in patients with schizophrenia; yet studies suggest that the ability 
to cope with symptoms (Ritsner et al. 2003) and the associated distress (Lasalvia et al. 2002; 
Ritsner et al. 2003), substantially contribute to QoL in schizophrenia, even more than symptom 
severity (Lasalvia et al. 2002; Ritsner et al. 2003). Therefore, reducing the negative emotional 
impact of psychosis and enhancing abilities to emotionally cope with illness may be at least as 
important as controlling symptoms (Stainsby et al. 2010). 
The link between the illness perception and QoL comes forward as a compelling target for 
research, and an important factor to be considered in clinical interventions. Learning how illness 
perceptions of a mental health problem relate to psychological and treatment outcomes would 
improve our understanding of behavior in patients with psychological disorders, leading to new 
applications and approaches to facilitate patients’ adjustment to their illness. Interventions 
addressing illness perceptions may encourage adherence to therapy, reduce inappropriate service 
use, and improve family and significant other relationships through analysis and therapy around 
aligning illness perceptions (Petrie et al. 2008). Likewise, targeting beliefs of young adults, in 
risk of or with mental health problems, about mental illness may prompt timely help-seeking 
(Vanheusden et al. 2009) reducing the gap between illness onset and treatment, in favor of 
outcome. 
Regardless of the limitations in mental health provision, our sample did not show markedly poor 
levels of QoL. This might well, at first, call into question the validity of the results; however, 
from a more positive approach towards psychotic illness other arguments must be considered. 
Results from the World Health Organization International Study of Schizophrenia (Jablensky et 
al. 1992) revealed that although the outcome of patients in the developing countries was not 
uniformly better as compared to the outcome in developed countries, high rates of complete 
clinical remission were significantly more common in the former. Furthermore, patients in 
developing countries experienced significantly longer periods of unimpaired functioning in the 
community, although only a small proportion (16 %) of them were on continuous antipsychotic 
medication (Jablensky et al. 1992; Jablensky and Sartorius 2008). For our sample, enrollment in 
treatment at the time of assessment did not have any significant impact on QoL. However, it 
must be underlined the fact that all patients had, at some point in time, received treatment; 
therefore, concluding that treatment makes no difference in terms of QoL would be erroneous. 
Moreover, the sample included not only schizophrenia cases but also those who have 
experienced milder types of psychoses (e.g. brief, delusional) and participation was not limited to 
patients still in need of treatment, but also cases that have achieved a satisfactory level of 
recovery. As our study did not focus exclusively on patients with an overall poor clinical status, 
results might well reflect the possibility of achieving a satisfactory level of recovery. 
The cultural background of the sample is an important factor to consider in relation to outcome, 
as data from Mexican general population have shown social- rather than monetary-oriented 
indicators to be core domains of QoL (Felix and Garcia-Vega 2012). Despite access to costly 
biomedical treatment, high rates of disability are more likely in high income countries, 
suggesting that the highly competitive standards common in these cultures might diminish social 
support and negatively affect patients’ outcome (Jablensky and Sartorius2008). Caregivers of 
Mexican origin seem particularly accepting of their relative’s psychotic illness, showing non-
blaming and low aversive responses to patient’s behavior (Dorian et al. 2008). These conditions 
might play a core role in the patients’ functional reintegration and perception of QoL; thus, the 
social factors favoring satisfactory levels of outcome in this culture (e.g. family attitudes) come 
forward as an important focus of future research. 
The uniqueness of our sample and the restrictive selection criteria may be of concern when 
discussing the implications of our results. Nevertheless, research with not well-known 
populations might well contribute to replicate previous findings from other countries and to cue 
on particular characteristics of patients that might be highly influenced by culture. 
Including patients with other types of psychoses and even other mental disorders, as well as 
patients from other locations would enrich future studies. A prospective design would strength 
the reliable assessment and control of important outcome predictors to be considered such as 
treatment compliance, medication adherence and substance abuse. Furthermore, the 
measurement of a more ample number of potential sociodemographic, clinical, social and 
treatment factors previously associated with QoL, must be considered. 
Conclusions 
Residual symptoms, rather than a relapsing course or diagnosis of schizophrenia, have a 
diminishing effect in the subjective QoL of Mexican patients with psychosis. This effect is fully 
mediated by illness perception, particularly by negative cognitive and emotional representations. 
Results underscore the importance that patients’ beliefs have on their perceived QoL, 
encouraging further research and development of interventions targeting illness perceptions. 
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